Q32 Bio (QTTB) EBT Margin (QoQ) (2018 - 2023)

Q32 Bio (QTTB) EBT Margin (QoQ) (2018 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn -
2 Nanobiotix 1,908.96 Bn 1,908.90 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 474.03 Bn 469.24 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.96 Bn 50.77 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn
10 Q32 Bio 215.66 Mn 164.91 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 272,288.00
Sep 30, 2023 -57,008.00
Jun 30, 2023 5,085.00
Mar 31, 2023 388,754.00
Dec 31, 2022 -18,030.00
Sep 30, 2022 -46,883.00
Jun 30, 2022 -1.51 Mn
Mar 31, 2022 1.59 Mn
Dec 31, 2021 -236,224.00
Sep 30, 2021 -43,056.00
Jun 30, 2021 -139,094.00
Mar 31, 2021 1.58 Mn
Dec 31, 2020 -707,448.00
Sep 30, 2020 142,116.00
Jun 30, 2020 -81,318.00
Mar 31, 2020 96,572.00
Dec 31, 2019 243,337.00
Sep 30, 2019 186,307.00
Jun 30, 2019 1.48 Mn
Mar 31, 2019 -2.47 Mn